All In MedTech

Device Trial Radar · NCT03830216

Connected Pens for Diabetes Study

Last checked: Nov 21, 2026Latest source record: Jan 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

21

Actual

Start

May 30, 2019

Primary completion

Nov 12, 2019

Study completion Nov 12, 2019

Sponsor

Lead sponsor
Companion Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 5, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to evaluate the impact of a wireless smart insulin pen and smartphone-based bolus advisor on clinical and psychosocial outcomes in insulin-treated diabetes mellitus patients after 3 months of use.

Conditions

  • Diabetes Mellitus

Interventions

  • Connected insulin pen and smartphone appDevice

    The InPen system is a reusable pen injector for single-patient use by people with diabetes age 12 and older for the self-injection of a desired dose of insulin. The pen injector is paired with a smartphone app with dose calculator.

  • Inactive connected insulin pen without smartphone appDevice

    The InPen system is a reusable pen injector for single-patient use by people with diabetes age 12 and older for the self-injection of a desired dose of insulin. The pen injector is inactive and not paired with a smartphone app or dose calculator.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CGM time in rangeTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mary & Dick Allen Diabetes Center, Hoag Memorial Hospital Presbyterian

    Newport Beach, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.